J Knee Surg 2022; 35(01): 021-025
DOI: 10.1055/s-0040-1710546
Original Article

Impact of Parkinson's Disease on Complications, Readmission Rates, and Costs of Care following Primary Total Knee Arthroplasty

Kevin B. Marchand
1   Northwell Health Orthopedics, Lenox Hill Hospital, New York, New York
,
Rushabh Vakharia
2   Department of Orthopedic Surgery, Holy Cross Hospital, Trinity Health, Fort Lauderdale, Florida
,
Nipun Sodhi
3   Northwell Health Orthopedics, Long Island Jewish Medical Center, New York, New York
,
Hiba Anis
4   Department of Orthopedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
,
Hytham S. Salem
1   Northwell Health Orthopedics, Lenox Hill Hospital, New York, New York
,
Giles R. Scuderi
1   Northwell Health Orthopedics, Lenox Hill Hospital, New York, New York
,
Michael A. Mont
1   Northwell Health Orthopedics, Lenox Hill Hospital, New York, New York
,
Martin William Roche
2   Department of Orthopedic Surgery, Holy Cross Hospital, Trinity Health, Fort Lauderdale, Florida
› Author Affiliations

Abstract

Large-scale studies evaluating the effects of Parkinson's disease (PD) on primary total knee arthroplasty (TKA) are limited. The purpose of this study was to determine if PD patients undergoing primary TKA have increased: (1) medical complications; (2) implant-related complications; (3) readmission rates; and (4) costs. A query was performed using an administrative claims database. The study group consisted of all patients undergoing primary TKA who had a history of PD. Matched non-PD patients undergoing primary TKA served as a control group. The query yielded 72,326 patients (PD = 18,082; matching cohort = 54,244). Pearson's chi-square tests, logistic regression analyses, and Welch's t-tests were used to test for significance between the cohorts. Primary TKA patients who had PD were found to have greater incidences and odds of medical complications (4.21 vs. 1.24%; odds ratio [OR]: 3.50, 95% confidence interval [CI]: 3.15–3.89, p < 0.0001) and implant-related complications (5.09 vs. 3.15%; OR: 1.64, 95% CI: 1.51–1.79, p < 0.0001) compared with the matching cohort. Additionally, the rates and odds of 90-day readmission were higher (16.29 vs. 12.66%; OR:1.34, p < 0.0001) and episodes of care costs were significantly greater ($17,105.43 vs. $15,252.34, p< 0.0001) in patients who had PD. Results demonstrate that PD patients undergoing primary TKA had higher incidences of medical and implant-related complications. They also had increased 90-day readmission rates and costs compared with controls. The findings of this study should be used in risk stratification and should inform physician–patient discussion but should not be arbitrarily used to deny access to care.



Publication History

Received: 03 February 2020

Accepted: 31 March 2020

Article published online:
27 May 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol 2016; 15 (12) 1257-1272
  • 2 Elbaz A, Bower JH, Maraganore DM. et al. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol 2002; 55 (01) 25-31
  • 3 Béné R, Antić S, Budisić M. et al. Parkinson's disease. Acta Clin Croat 2009; 48 (03) 377-380
  • 4 Poewe W. The natural history of Parkinson's disease. J Neurol 2006; 253 (Suppl. 07) VII2-VII6
  • 5 Zuckerman LM. Parkinson's disease and the orthopedic patient. J Am Acad Orthop Surg 2009; 17 (01) 48-55
  • 6 Aita JF. Why patients with Parkinson's disease fall. JAMA 1982; 247 (04) 515-516
  • 7 Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014; 85 (10) 1159-1166
  • 8 Johnell O, Melton III LJ, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing 1992; 21 (01) 32-38
  • 9 Lee J, Choi M, Jung D, Sohn YH, Hong J. A structural model of health-related quality of life in Parkinson's disease patients. West J Nurs Res 2015; 37 (08) 1062-1080
  • 10 Diamond SG, Markham CH. Present morality in Parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths. J Neural Transm (Vienna) 1976; 38 (3-4): 259-269
  • 11 Leibson CL, Maraganore DM, Bower JH, Ransom JE, O'brien PC, Rocca WA. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006; 21 (04) 446-455
  • 12 Newman JM, Sodhi N, Wilhelm AB. et al. Parkinson's disease increases the risk of perioperative complications after total knee arthroplasty: a nationwide database study. Knee Surg Sports Traumatol Arthrosc 2019; 27 (07) 2189-2195
  • 13 Fast A, Mendelsohn E, Sosner J. Total knee arthroplasty in Parkinson's disease. Arch Phys Med Rehabil 1994; 75 (11) 1269-1270
  • 14 Kleiner JE, Gil JA, Eltorai AEM, Rubin LE, Daniels AH. Matched cohort analysis of peri-operative outcomes following total knee arthroplasty in patients with and without Parkinson's disease. Knee 2019; 26 (04) 876-880
  • 15 Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson's disease in the United States. Mov Disord 2013; 28 (03) 311-318
  • 16 Blackstone EA, Fuhr Jr JP. The economics of medicare accountable care organizations. Am Health Drug Benefits 2016; 9 (01) 11-19
  • 17 Sodhi N, Piuzzi NS, Khlopas A. et al. Are we appropriately compensated by relative value units for primary vs revision total hip arthroplasty?. J Arthroplasty 2018; 33 (02) 340-344
  • 18 Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36 (01) 8-27
  • 19 Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopedic surgery. Clin Orthop Relat Res 2014; 472 (09) 2878-2886
  • 20 Vakharia RM, Cohen-Levy WB, Vakharia AM, Donnally CJ, Law TY, Roche MW. Sleep apnea increases ninety-day complications and cost following primary total joint arthroplasty. J Arthroplasty 2019; 34 (05) 959-964
  • 21 Vakharia RM, Sabeh K, Sodhi N, Naziri Q, Mont MA, Roche MW. Implant related complications among patients with opioid use disorder following primary total hip arthroplasty: a matched-control analysis of 42,097 medicare patients. J Arthroplasty 2020; 35 (01) 178-181
  • 22 Ardeljan A, Menses Z, Neal B, Vakharia RM. Increased medical complications, revisions, in-hospital lengths of stay, and cost in patients with hypogonadism undergoing primary total knee arthroplasty. J Arthroplasty 2020; 35 (01) 95-99
  • 23 Rondon AJ, Tan TL, Schlitt PK, Greenky MR, Phillips JL, Purtill JJ. Total joint arthroplasty in patients with Parkinson's disease: survivorship, outcomes, and reasons for failure. J Arthroplasty 2018; 33 (04) 1028-1032
  • 24 Jämsen E, Puolakka T, Peltola M, Eskelinen A, Lehto MU. Surgical outcomes of primary hip and knee replacements in patients with Parkinson's disease: a nationwide registry-based case-controlled study. Bone Joint J 2014; 96-B (04) 486-491
  • 25 Duffy GP, Trousdale RT. Total knee arthroplasty in patients with Parkinson's disease. J Arthroplasty 1996; 11 (08) 899-904
  • 26 Yli-Kyyny TT, Sund R, Heinänen M, Malmivaara A, Kröger H. Risk factors for early readmission due to surgical complications after treatment of proximal femoral fractures—a Finnish National Database study of 68,800 patients. Injury 2019; 50 (02) 403-408
  • 27 Sofu H, Üçpunar H, Çamurcu Y. et al. Predictive factors for early hospital readmission and 1-year mortality in elder patients following surgical treatment of a hip fracture. Ulus Travma Acil Cerrahi Derg 2017; 23 (03) 245-250